Literature DB >> 21794194

Vulvodynia interventions--systematic review and evidence grading.

Jeffrey C Andrews1.   

Abstract

INTRODUCTION: State of the art guidance exists for management of vulvodynia, but the scientific basis for interventions has not been well described. Although there are many interventional therapies, and their use is increasing, there is also uncertainty or controversy about their efficacy.
OBJECTIVE: To systematically assess benefits and harms of interventional therapies for vulvodynia and vestibulodynia.
METHODS: The following databases were searched, using MeSH terms for studies related to the treatment of vulvodynia or vulva pain/pruritus/dysesthesia/hyperesthesia/hypersensitivity: MEDLINE, PsycINFO, Scopus, Cochrane Library, EBSCO Academic, and Google Scholar. Using Medical Subject Reference sections of relevant original articles, reviews, and evidence-based guidelines were screened manually. Manual searching for indirect evidence supporting interventions was done whenever no direct evidence was found for a treatment described within a review or guideline. Each modality is assessed with a grading system similar to the Grades of Recommendation, Assessment, Development, and Evaluation system. The grading system assesses study quality, effect size, benefits, risks, burdens, and costs.
RESULTS: For improvement of pain and/or function in women with vestibulodynia (provoked localized vulvodynia), there was fair evidence that vestibulectomy was of benefit, but the size of the effect cannot be determined with confidence. There was good evidence of a placebo effect from multiple studies of nonsurgical interventions. There was fair evidence of lack of efficacy for several nonsurgical interventions. There were several interventions for which there were insufficient evidence to reliably evaluate. There was insufficient evidence to judge harms or to judge long-term benefits. For clinically meaningful improvement of pain in women with generalized unprovoked vulvodynia, there was insufficient evidence for benefit of any intervention. There was fair evidence of a placebo effect in people with neuropathic pain and functional pain syndromes, from multiple studies of interventions. Based on indirect evidences from studies of patients with other pain disorders, interventions may be selected for future research.
CONCLUSION: There is fair evidence for effectiveness of vestibulectomy for vestibulodynia; however, there is uncertainty about the size of the absolute effect, because of the risk of bias inherent in studies of pain interventions without a placebo control group. Providers and patients looking for evidence-based interventions for generalized unprovoked vulvodynia may need to rely on indirect evidences from studies of neuropathic pain and functional pain syndromes. TARGET AUDIENCE: Obstetricians & gynecologists, family physicians. LEARNING
OBJECTIVES: After completion of this educational activity, the obstetrician/gynecologist should be better able to identify potential causes of vulvar pain to facilitate diagnosis of vulvodynia and vestibulodynia, distinguish between the symptoms of localized, provoked vulvodynia and generalized unprovoked vulvodynia to select the most appropriate therapies, evaluate the efficacy of surgical and nonsurgical interventions for the treatment of generalized unprovoked and localized, provoked vulvodynia. In addition, assess the benefits and risks of interventional therapies for vulvodynia and vestibulodynia to improve patient care.

Entities:  

Mesh:

Year:  2011        PMID: 21794194     DOI: 10.1097/OGX.0b013e3182277fb7

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  22 in total

Review 1.  A psychosocial approach to female genital pain.

Authors:  Marieke Dewitte; Charmaine Borg; Lior Lowenstein
Journal:  Nat Rev Urol       Date:  2017-11-28       Impact factor: 14.432

2.  Myotonometry Reliably Measures Muscle Stiffness in the Thenar and Perineal Muscles.

Authors:  Melissa J Davidson; Adam L Bryant; Wendy F Bower; Helena C Frawley
Journal:  Physiother Can       Date:  2017       Impact factor: 1.037

3.  Perceived stereotyping and seeking care for chronic vulvar pain.

Authors:  Ruby H N Nguyen; Rachael M Turner; Sarah A Rydell; Richard F Maclehose; Bernard L Harlow
Journal:  Pain Med       Date:  2013-06-06       Impact factor: 3.750

Review 4.  Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies.

Authors:  Yona Tadir; Adrian Gaspar; Ahinoam Lev-Sagie; Macrene Alexiades; Red Alinsod; Alex Bader; Alberto Calligaro; Jorge A Elias; Marco Gambaciani; Jorge E Gaviria; Cheryl B Iglesia; Ksenija Selih-Martinec; Patricia L Mwesigwa; Urska B Ogrinc; Stefano Salvatore; Paolo Scollo; Nicola Zerbinati; John Stuart Nelson
Journal:  Lasers Surg Med       Date:  2017-02-21       Impact factor: 4.025

5.  Disease-Related Microstructural Differences in the Brain in Women With Provoked Vestibulodynia.

Authors:  Arpana Gupta; Davis C Woodworth; Benjamin M Ellingson; Andrea J Rapkin; Bruce Naliboff; Lisa A Kilpatrick; Jean Stains; Salome Masghati; Kirsten Tillisch; Emeran A Mayer; Jennifer S Labus
Journal:  J Pain       Date:  2018-01-31       Impact factor: 5.820

Review 6.  Botulinum toxin for conditions of the female pelvis.

Authors:  Dominique El-Khawand; Salim Wehbe; Kristene Whitmore
Journal:  Int Urogynecol J       Date:  2013-01-24       Impact factor: 2.894

7.  Rationale and design of a multicenter randomized clinical trial of extended release gabapentin in provoked vestibulodynia and biological correlates of response.

Authors:  Candace S Brown; David C Foster; Jim Y Wan; Leslie A Rawlinson; Gloria A Bachmann
Journal:  Contemp Clin Trials       Date:  2013-06-29       Impact factor: 2.226

8.  Vestibular Mast Cell Density in Vulvodynia: A Case-Controlled Study.

Authors:  Dimitrios Papoutsis; Hope K Haefner; Christopher P Crum; Anthony W Opipari; Barbara D Reed
Journal:  J Low Genit Tract Dis       Date:  2016-07       Impact factor: 1.925

9.  Patterns in Vulvodynia Treatments and 6-Month Outcomes for Women Enrolled in the National Vulvodynia Registry-An Exploratory Prospective Study.

Authors:  Georgine Lamvu; Meryl Alappattu; Kathryn Witzeman; Mark Bishop; Michael Robinson; Andrea Rapkin
Journal:  J Sex Med       Date:  2018-04-07       Impact factor: 3.802

Review 10.  A review of the available clinical therapies for vulvodynia management and new data implicating proinflammatory mediators in pain elicitation.

Authors:  M L Falsetta; D C Foster; A D Bonham; R P Phipps
Journal:  BJOG       Date:  2016-06-17       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.